DAIICHI KAGAKU YAKUHIN KABUSHIKI KAISHA – Trademark Portfolio
Entity Type: 03
DAIICHI KAGAKU YAKUHIN KABUSHIKI KAISHA holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MULTIGEL. The owner is based in Chuo-Ku, Tokyo.
13-5, Nihombashi 3-Chome
Chuo-Ku, Tokyo , JP
Showing of trademarks Trademarks
Trademark Classifications
DAIICHI KAGAKU YAKUHIN KABUSHIKI KAISHA's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does DAIICHI KAGAKU YAKUHIN KABUSHIKI KAISHA have?
DAIICHI KAGAKU YAKUHIN KABUSHIKI KAISHA has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.
What trademark classes does DAIICHI KAGAKU YAKUHIN KABUSHIKI KAISHA file in?
DAIICHI KAGAKU YAKUHIN KABUSHIKI KAISHA files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are DAIICHI KAGAKU YAKUHIN KABUSHIKI KAISHA's most well-known trademarks?
DAIICHI KAGAKU YAKUHIN KABUSHIKI KAISHA's registered trademark portfolio includes well-known marks such as MULTIGEL. These are among 1 currently registered trademark in the portfolio.
What is DAIICHI KAGAKU YAKUHIN KABUSHIKI KAISHA's trademark registration success rate?
DAIICHI KAGAKU YAKUHIN KABUSHIKI KAISHA has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.